These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23357167)
21. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy. Dandel M; Wallukat G; Potapov E; Hetzer R Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755 [TBL] [Abstract][Full Text] [Related]
22. Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study. Schimke I; Müller J; Dandel M; Gremmels HD; Bayer W; Wallukat B; Wallukat G; Hetzer R J Clin Apher; 2005 Oct; 20(3):137-42. PubMed ID: 15892087 [TBL] [Abstract][Full Text] [Related]
23. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy. Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721 [TBL] [Abstract][Full Text] [Related]
24. [Apheresis of immunoglobulins - new approach to the treatment of severe dilated cardiomyopathy]. Konovalov GA; Belenkov IuN; Zvezdkin PV; Chebyshev AN; Semin SN; Kuznetsova IuV; Adamova IIu; Kipor SG; Pokrovskiĭ SN Kardiologiia; 2002; 42(6):92-6. PubMed ID: 12494138 [TBL] [Abstract][Full Text] [Related]
25. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502 [TBL] [Abstract][Full Text] [Related]
26. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. Nikolaev VO; Boivin V; Störk S; Angermann CE; Ertl G; Lohse MJ; Jahns R J Am Coll Cardiol; 2007 Jul; 50(5):423-31. PubMed ID: 17662395 [TBL] [Abstract][Full Text] [Related]
27. Apheresis in the treatment of idiopathic dilated cardiomyopathy. Winters JL J Clin Apher; 2012; 27(6):312-9. PubMed ID: 22811302 [TBL] [Abstract][Full Text] [Related]
29. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. Badenhorst D; Norton GR; Sliwa K; Brooksbank R; Essop R; Sareli P; Woodiwiss AJ Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186 [TBL] [Abstract][Full Text] [Related]
30. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure. Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286 [TBL] [Abstract][Full Text] [Related]
31. Dilated cardiomyopathy with hypertension: prevalence and response to high-dose β1-adrenoceptor antagonist therapy. Zheng X; Chen S; Wang J; Yang T; Chen Y Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):945-9. PubMed ID: 19473337 [TBL] [Abstract][Full Text] [Related]
32. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135 [TBL] [Abstract][Full Text] [Related]
33. [The role of anti-beta1-adrenergic receptor autoantibodies in development of heart failure]. Tonevitskiĭ AG; Tabak'an EA Ross Fiziol Zh Im I M Sechenova; 2006 Mar; 92(3):330-41. PubMed ID: 16739643 [TBL] [Abstract][Full Text] [Related]
34. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Doesch AO; Mueller S; Nelles M; Konstandin M; Celik S; Frankenstein L; Goeser S; Kaya Z; Koch A; Zugck C; Katus HA Basic Res Cardiol; 2011 Jan; 106(1):25-35. PubMed ID: 20957484 [TBL] [Abstract][Full Text] [Related]
35. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975 [TBL] [Abstract][Full Text] [Related]
37. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry. Ohlow MA; Brunelli M; Schreiber M; Lauer B J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513 [TBL] [Abstract][Full Text] [Related]